Hims & Hers (HIMS) Director Delos M. Cosgrove Receives RSU Award

What Happened
Delos M. Cosgrove, a director of Hims & Hers Health, Inc. (HIMS), received a grant of 8,223 restricted stock units (RSUs) on 2026-08-12. The Form 4 reports the award as a derivative acquisition at $0.00 per unit (no cash paid at grant). RSUs are a contingent right to receive one share of Class A common stock per RSU and do not represent immediate shares until they vest and are issued.

Key Details

• Transaction date: 2026-08-12; reported on Form 4 filed 2026-08-14 (timely filing).
• Award: 8,223 RSUs granted; reported price $0.00 (no cash exchanged at grant).
• Shares owned after transaction: Not specified in the filing.
• Footnote (important): RSUs vest in full on the first Company quarterly vesting date that occurs after the earlier of (x) the Company’s next annual stockholder meeting or (y) the first anniversary of the grant date, provided continuous service.
• No 10b5-1 plan, tax withholding, or sale noted in this filing.

Context
RSUs are a form of equity compensation that convert into shares only after vesting; they are not the same as an open-market purchase or sale. Grants like this are routine for compensation or retention and do not by themselves indicate an insider buying or selling stock in the market.